USPTO Examiner KIM SUN U - Art Unit 1777

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19281579METHOD OF PHOTOCATALYTIC DEGRADATION OF A POLLUTANT USING NANOCOMPOSITEJuly 2025September 2025Allow200NoNo
19110792A DIALYSIS APPARATUS WHICH ULTRA-FILTERS BLOOD AND A RELATED METHODMarch 2025December 2025Allow920NoNo
19071140DEVICES AND METHODS FOR REMOVING CANCER CELLS FROM BLOODSTREAM DURING CANCER METASTASISMarch 2025September 2025Allow620NoNo
19055052SYSTEM AND PROCESS FOR REDUCING PFAS AND MICROPLASTICS IN BIOSOLIDS USING HYDRODYNAMIC CAVITATION AND FOAM FRACTIONATIONFebruary 2025July 2025Allow510NoNo
18867141DIALYSIS SYSTEM HAVING ENHANCED VALVE FEATURESNovember 2024April 2025Allow500NoNo
18936404METHOD AND SYSTEM FOR SUSTAINABLE BRINE TREATMENT AND HEAVY METAL PURIFICATION USING RECYCLED CARBON FIBERNovember 2024April 2025Allow610NoNo
18893058PROCESS OF PURIFICATION OF PROTEINSeptember 2024January 2025Allow400NoNo
18824560KITCHEN WASTE WASTEWATER TREATMENT EQUIPMENTSeptember 2024October 2024Allow200NoNo
18805922INTEGRATED RAPID TREATMENT SYSTEM FOR NUCLEAR MEDICAL RADIOACTIVE WASTEWATER AND APPLICATION METHOD THEREOFAugust 2024October 2024Allow200NoNo
18797446SULFUR-MOLYBDENUM CLUSTER MODIFIED MOF MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOFAugust 2024October 2024Allow200NoNo
18756677PRASEODYMIUM-DOPED UPCONVERSION PHOSPHORJune 2024September 2024Allow300NoNo
18747386Outdoor Water PurifierJune 2024September 2024Allow300NoNo
18653906COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2024October 2024Allow501NoNo
18653903COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2024February 2025Allow920YesNo
18651805SYSTEM AND PROCESS FOR REDUCING PFAS AND MICROPLASTICS IN BIOSOLIDS USING HYDRODYNAMIC CAVITATION AND FOAM FRACTIONATIONMay 2024January 2025Allow901NoNo
18648343Membrane Fouling Early Warning Method and Device Based on Machine LearningApril 2024July 2024Allow300NoNo
18631965FILTER ELEMENT MOUNTING STRUCTUREApril 2024June 2024Allow200NoNo
18619120DEVICE FOR TREATING URANIUM TAILINGS WITH MICROORGANISMMarch 2024July 2024Allow400NoNo
18607187MODIFIED TNF AS A CAPTURE LIGANDMarch 2024March 2026Abandon2410NoNo
18605528Hemofilter For In Vivo Blood FiltrationMarch 2024February 2025Allow1110NoNo
18595901METHOD AND SYSTEM FOR SUSTAINABLE BRINE TREATMENT AND HEAVY METAL PURIFICATION USING RECYCLED CARBON FIBERMarch 2024August 2024Allow501NoNo
18595191APPARATUS FOR SUPPLEMENTING FUNCTION OF ENDOCRINE GLANDSMarch 2024May 2025Allow1410NoNo
18593221STERILE INTERFACE CONNECTION OF A DISPOSABLE SOURCE OF DIALYSATE CONCENTRATESMarch 2024July 2025Allow1610NoNo
18584581TRI-METALLIC ORGANIC FRAMEWORK (MOF) COMPLEX AS A REDUCTION CATALYSTFebruary 2024June 2024Allow401NoNo
18577901APPARATUS AND PROCESS FOR REMOVING PFAS AND PFAS COMPOUNDS FROM WATERJanuary 2024June 2024Allow500NoNo
18407456WATER PURIFICATION, STERILIZATION AND DISINFECTION LAMPJanuary 2024April 2024Allow300NoNo
18575510Environmental barge for filtering oil from water in the spill response to oil pollution at seaDecember 2023March 2026Allow2600NoNo
18400507ABSOLUTE BLOOD VOLUME ESTIMATION DEVICE AND METHODDecember 2023November 2024Allow1100NoNo
18543952SYSTEM FOR REMOVING UREMIC TOXINS IN DIALYSIS PROCESSESDecember 2023January 2026Allow2510NoNo
18570954Method for Regulating the Addition of a Flocculant to a SludgeDecember 2023February 2026Allow2600NoNo
18539694DIALYSIS SYSTEM HAVING MOTOR DRIVER PRESSURE ESTIMATION OF FLUID WITHIN A PATIENT LINEDecember 2023February 2026Allow2600NoNo
18567900PERISTALTIC PUMPING DEVICE AND MEDICAL APPARATUS, IN PARTICULAR FOR DIALYSIS, INCORPORATING ITDecember 2023January 2026Allow2600NoNo
18528305DIALYSIS SYSTEM HAVING A VALVE FUNCTIONALITY ASSESSMENTDecember 2023February 2026Allow2600NoNo
18517029MEMBRANE SYSTEM TO TREAT LEACHATE AND METHODS OF TREATING LEACHATENovember 2023October 2025Allow2311NoNo
18561198CAPSULE DEVICE WITH AN APERTURE FORMED BY AN OVERLAP OF TWO HALVE-CAPSULE SHELLSNovember 2023March 2026Allow2800NoNo
18491072DEVICE FOR FORMING A MEDICAL PASTEOctober 2023August 2024Allow1010NoNo
18287800COMPOSITE SEMIPERMEABLE MEMBRANEOctober 2023July 2024Allow810NoNo
18375184HYDROCARBON FLUID-WATER SEPARATIONSeptember 2023August 2025Allow2340NoNo
18367073DIALYSIS SYSTEM HAVING EXTERNAL TUBING SURFACE CLEANINGSeptember 2023March 2026Allow3010NoNo
18456122ELECTRICAL PLUG FOR A DIALYSIS MACHINEAugust 2023August 2024Allow1210NoNo
18452516HEMODIALYSIS SYSTEMS AND METHODSAugust 2023April 2024Allow800NoNo
18365090DEVICES FOR EFFICIENT SORBENT UTILIZATION IN LITHIUM EXTRACTIONAugust 2023January 2024Allow600NoNo
18262989SEPARATION APPARATUS AND METHODJuly 2023March 2026Allow3211NoNo
18358840BLOOD CIRCUIT ASSEMBLY FOR A HEMODIALYSIS SYSTEMJuly 2023February 2024Allow700NoNo
18224127Treatment Fluid Multi-Stream Blood WarmerJuly 2023August 2024Allow1301NoNo
18219938SYSTEM AND METHOD FOR CARDIOPULMONARY BYPASS USING HYPOBARIC OXYGENATIONJuly 2023February 2024Allow800NoNo
18346174BLOOD TREATMENT SYSTEMS AND METHODSJune 2023July 2024Allow1320NoNo
18216565Extracorporeal oxygenation system for low flow rates and methods of useJune 2023July 2025Allow2430NoNo
18215269DIALYSIS SYSTEM HAVING LOW VOLUME PERITONEAL DIALYSIS PATIENT FILL TEMPERATURE CONTROLJune 2023December 2025Allow3001NoNo
18215528DIALYSIS SYSTEM HAVING ENHANCED FEATURES INCLUDING DRIP PREVENTIONJune 2023September 2025Allow2700NoNo
18215448DIALYSIS SYSTEM HAVING FILTER TESTINGJune 2023September 2025Allow2600NoNo
18269590PERITONEAL DIALYSIS SYSTEM INCLUDING PERISTALTIC PUMPJune 2023January 2026Allow3000NoNo
18269652PERITONEAL DIALYSIS SYSTEM HAVING DISINFECTION FLUID PUMPING AND PATHWAYJune 2023October 2023Allow400NoNo
18268534UNIT FOR FILTERING LEUKOCYTES WITH REDUCED PLATELET ADHESIONJune 2023March 2026Allow3310NoNo
18211778AUTOMATIC PLASMA SEPARATION AND METERINGJune 2023February 2025Allow2011NoNo
18210228PERITONEAL DIALYSIS CIRCUITJune 2023December 2025Allow3010NoNo
18335367PERITONEAL DIALYSIS SYSTEM HAVING DISINFECTION GAS RELIEFJune 2023January 2026Allow3210NoNo
18256781METHOD FOR CALIBRATING A PERISTALTIC PUMP IN A MEDICAL APPARATUS AND MEDICAL APPARATUS FOR PERFORMING THIS METHODJune 2023September 2025Allow2700NoNo
18256740MANIFOLD ASSEMBLY FOR A PERITONEAL DIALYSIS APPARATUS AND PERITONEAL DIALYSIS APPARATUS COMPRISING SAID MANIFOLD ASSEMBLYJune 2023December 2025Allow3010NoNo
18266225MEDICAL APPARATUSJune 2023October 2025Allow2800NoNo
18266224MANIFOLD ASSEMBLY FOR A PERITONEAL DIALYSIS APPARATUS AND PERITONEAL DIALYSIS APPARATUS COMPRISING SAID MANIFOLD ASSEMBLYJune 2023August 2025Allow2600NoNo
18204306COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023August 2024Allow1431YesNo
18204293COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023February 2024Allow911YesNo
18204305COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023March 2024Allow1011NoNo
18323077Blood Processing Apparatus and Method forDestroying Cancer Metastasis In VivoMay 2023April 2024Allow1111NoNo
18323055Blood Processing Apparatus and Method for Detoxifying Bacterial Lipopolysaccharide In VivoMay 2023April 2024Allow1111NoNo
18200666Treatment Fluid Devices Methods and SystemsMay 2023November 2025Allow2901NoNo
18200119WEARABLE MODULAR EXTRACORPOREAL LIFE SUPPORT DEVICE FOR MOBILE TREATMENT OF SINGLE AND MULTIORGAN FAILUREMay 2023August 2024Allow1511NoNo
18036496BALLOON FOR BALLOON CATHETERMay 2023March 2026Allow3410YesNo
18143733Blood Treatment Device Priming Devices, Methods, and SystemsMay 2023December 2023Allow801NoNo
18138711CASSETTE SYSTEM INTEGRATED APPARATUSApril 2023March 2024Allow1010NoNo
18033268MEDICAL FLUID GENERATION SYSTEMApril 2023January 2026Allow3301NoNo
18032761MEDICAL FLUID GENERATION SYSTEMApril 2023January 2026Allow3301NoNo
18249459WEIGHT-BASED PERITONEAL DIALYSIS SYSTEM INCLUDING A DRAIN TROLLEYApril 2023December 2025Allow3210NoNo
18031819MOBILE MEDICAL FLUID GENERATION SYSTEMApril 2023August 2025Allow2800NoNo
18130635BLOOD PLASMA SEPARATION DEVICEApril 2023November 2023Allow800NoNo
18125374PERITONEAL DIALYSIS SYSTEM AND METHOD FOR MINIMIZING PATIENT DRAIN PAINMarch 2023July 2025Allow2800NoNo
18171636EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023January 2024Allow1120NoNo
18171640EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023March 2024Allow1321NoNo
18171637EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023July 2023Allow500NoNo
18042176PERITONITIS SENSORS, INCLUDING PERITONITIS SENSORS FOR AUTOMATED PERITONEAL DIALYSIS SYSTEMS, AND ASSOCIATED SYSTEMS, DEVICES, AND METHODSFebruary 2023January 2026Allow3511YesNo
18109547SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMESFebruary 2023June 2023Allow420NoNo
18020189AIR-POWERED PERITONEAL DIALYSIS SYSTEM WITH NESTING CONTAINERSFebruary 2023August 2025Allow3101NoNo
18020199AIR-POWERED PERITONEAL DIALYSIS SYSTEM WITH INFLATABLE BLADDERSFebruary 2023August 2025Allow3000NoNo
18019442WEARABLE AUTOMATED PERITONEAL DIALYSIS DEVICEFebruary 2023February 2026Allow3611NoNo
18018944DIALYSIS SYSTEM AND METHOD INCLUDING A FLOW PATH INSULATORJanuary 2023November 2025Allow3310NoNo
18103458CONTROL SYSTEMS AND METHODS FOR BLOOD OR FLUID HANDLING MEDICAL DEVICESJanuary 2023February 2024Allow1320NoNo
18017619PRESSURE SENSORS, INCLUDING PRESSURE SENSORS FOR AUTOMATED PERITONEAL DIALYSIS SYSTEMS, AND ASSOCIATED SYSTEMS, DEVICES, AND METHODSJanuary 2023July 2025Allow2900NoNo
18094820ULTRAPURE WATER SUPPLY APPARATUS, SUBSTRATE PROCESSING SYSTEM INCLUDING THE SAME, AND SUBSTRATE PROCESSING METHOD USING THE SAMEJanuary 2023August 2024Allow1901NoNo
18015030DIALYSIS SYSTEMSJanuary 2023February 2026Abandon3810NoNo
18147133PERITONEAL DIALYSIS CYCLER HAVING DECREASED PH DISINFECTIONDecember 2022August 2025Allow3210NoNo
18147060PERITONEAL DIALYSIS SYSTEM HAVING AIR-AIDED PUMPING SEQUENCESDecember 2022July 2025Allow3101NoNo
18088169Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety DeviceDecember 2022March 2026Allow3910NoNo
18003205DEVICES FOR PERITONEAL DIALYSATE ANALYSISDecember 2022October 2025Allow3401NoNo
18088115Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety DeviceDecember 2022February 2026Allow3810NoNo
18083827COMPOUNDS, SYSTEMS, AND TECHNIQUES FOR REMOVAL OF PERIPHERAL AMYLOID BETA PEPTIDE WITH ALBUMIN BINDING COMPETITORSDecember 2022January 2026Allow3712NoNo
18083018TUBE TWIST TUBING OCCLUDERDecember 2022September 2025Allow3330NoNo
18081375PERITONEAL DIALYSIS SYSTEM HAVING CARBON DIOXIDE INJECTION TO INHIBIT/REMOVE CALCIUM CARBONATEDecember 2022April 2025Allow2800NoNo
18076362DEVICE FOR HOMOGENEOUS INJECTION OF MEDICINEDecember 2022March 2026Abandon3910NoNo
18008270AUTOMATED PERITONEAL DIALYSIS USING BELLOWSDecember 2022September 2025Allow3301NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, SUN U.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
1
(50.0%)
Examiner Reversed
1
(50.0%)
Reversal Percentile
71.0%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
30
Allowed After Appeal Filing
12
(40.0%)
Not Allowed After Appeal Filing
18
(60.0%)
Filing Benefit Percentile
65.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner KIM, SUN U - Prosecution Strategy Guide

Executive Summary

Examiner KIM, SUN U works in Art Unit 1777 and has examined 903 patent applications in our dataset. With an allowance rate of 81.0%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 32 months.

Allowance Patterns

Examiner KIM, SUN U's allowance rate of 81.0% places them in the 51% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by KIM, SUN U receive 1.57 office actions before reaching final disposition. This places the examiner in the 29% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KIM, SUN U is 32 months. This places the examiner in the 50% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +8.2% benefit to allowance rate for applications examined by KIM, SUN U. This interview benefit is in the 38% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 30.9% of applications are subsequently allowed. This success rate is in the 62% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 43.7% of cases where such amendments are filed. This entry rate is in the 67% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 109.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 79% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 91.7% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 54.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 60.2% are granted (fully or in part). This grant rate is in the 64% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.7% of allowed cases (in the 85% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.6% of allowed cases (in the 88% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.